CBLL 8-K 2026-11-03

Ceribell, Inc. (CBLL) 8-K dated 2026-11-03 — accession 0001193125-26-445487.

Ceribell, Inc. (CBLL) is a medical devices company listed on US.

CBLL: SECURITIES AND EXCHANGE COMMISSION

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CBLL revenue for 2025-12-31 was $89.1M. Net income was -$53.4M. Revenue was up 36.1% from 2024-12-31 to 2025-12-31. CBLL currently screens at market cap $768.1M.

Not investment advice. The CBLL SEC hub lists recent forms. The stock page is the research view.